网站首页 实验服务中心 学术服务 实验室采购 资讯动态 关于我们 联系我们 人才招聘
   
1
2
3
4
 
SCI论文
 

 

客服电话:021-34712376 

E-mail:yujin@yujinbio.com

网址:www.yujinbio.com


微信公众平台号:YuJinBio8


 
 
  您现在的位置:YuJinBio—专业科研临床服务中心 > SCI信息
第一次投稿 SCI ,有哪些要注意的?二
作者:酸菜
链接:https://www.zhihu.com/question/63803134/answer/274797182
来源:知乎
著作权归作者所有。商业转载请联系作者获得授权,非商业转载请注明出处。

三、图片

某些领域中,图片占有较大比重,没有图片的佐证任何论点都无法在文章中让人信服。偷懒+不影响阅读,我就直接放链接了,有需要的人随意戳SCI论文常用插图制作要点及方法

以及跟着13分文章学作图,等着收获SCI吧(origin8教程)


四、参考文献

参考文献是论文的最后一部分,也是好多论文的最差的一部分。

不少期刊的编辑一般通过参考文献找审稿人,所以引用一些近几年的文献可以给编辑提供方便,加快自己论文的发表速度。关键的参考文献一定要引用,在引言中对参考文献的评述一定要中肯、恰当,不然会被评阅人认为不了解研究背景,因此把你的论文毙掉。

使用恰当的文献管理工具,能让规范引文格式,大大提高效率。

参考文献也不是越多越好,太多参考文献可以理解为相关研究比较热,同时也可理解为你的文章可有可无。


五、选刊投稿

要选哪家期刊?老板和同组的大伙伴们都是很好的资源,因为你的研究方向肯定和他们有联系,请他们给你推荐合适的期刊。如果一定要你自力更生,那不妨反把他们发过的文章研究一下,他的哪种类型文章都投过哪些杂志,模仿起来。

如果你自己就是开山祖师……就从平时读过的文献里找吧。不过可能性太小,不多说。

从文章去找期刊有一个好处,因为每家期刊的宗旨、接收文章的类型都各有特色,要是直接找期刊的话你还要先了解各刊的胃口,对于只想发一篇文章的新手来说没什么卵用;倒追的话,这期刊都发过的类似的文章了肯定我这篇也在接收范围里。

还有一个小问题,新手往往不太自信,选择偏低分的期刊,于是就容易掉坑里。其实可以往高分的试试,万一被接收了呢?就算被拒,也许还能收到很有价值的意见。如果非要投不太主流的杂志,万一人家被踢出SCI了岂不是白发?(可以用Thomson Reuters网站下的Master Journal List工具来查询SCI是否收录该期刊)

目标刊物选定,就开始投稿吧。首先要给编辑写一封简洁有力又动人的cover letter,随稿件及其他补充材料一起上传到杂志网站的投稿系统。

Cover letter中比较重要的部分是审稿人的推荐,一般推荐3-4位,可以是国外研究方向与你相近的作者;或你文中引用的论文的作者;或自己熟悉的同专业的教授、副教授;再有就是在国际上有些影响的国内学者。如果你觉得有人跟你有利益冲突,不利于你文章发表,那么记得列个排除审稿人名单并说明理由,一般不超过3名。

接下来如果顺利,文章就进入同行评审,大概要等2-3个月才会有评审意见。这段时间可以稍作放松,但也别光用来吃喝玩睡,建议仍抽空继续关注文章相关领域,包括最新进展、既往文献中有没有当时被你漏掉的研究,再想想自己的实验,等审稿意见下来你要回复时,说不定会用到这些信息,有备无患。


六、投稿后:对待审稿修稿意见就该全盘接收?

首先,我们应该尊重审稿人,可以毫不夸张地说,在你的文章出版之前,甚至出版之后,没有几个人会像审稿人那样仔细体会和分析你的文章。

因此,我们应该充满感激、也认真思考和领会他们所提出的每一条意见,甚至是近乎苛刻的意见,但也不卑不亢。对于审稿人提出的意见,切忌“硬碰硬”,回复技巧很重要。

技巧1:先礼后兵,礼貌开头

Thank you for your letter and for the reviewers’ comments concerning our manuscript entitled “文章题目”. These comments are all valuable and very helpful for revising and improving our paper, as well as the important guiding significance to our researches. We have studied comments carefully and have made corrections which we hope meet with approval. (你的提议太有用了,我论文的质量蹭蹭蹭就上去了!我们相当仔细研究了你的建议之类的话)The responds to the reviewer’s comments are as follows: .......

技巧2:细节修改,不容小觑,一一作答,有礼有节

比如审稿人提出:图中需要补充比例尺

回复:As for the referee’s concern, we have added scale bars to the Figures.

比如审稿人提出:部分图片没有显著性差异

回复:As for the referee’s concern, we have indicated a significant difference with asterisk in figures.

比如审稿人提出:通篇语言问题不过关

回复:We are very sorry for the mistakes in this manuscript and inconvenience they caused in your reading. The manuscript has been thoroughly revised and edited by a native speaker, so we hope it can meet the journal’s standard. Thanks so much for your useful comments.

比如审稿人提出:补充缩写词的全称

回复:As for the referee’s concern, the full descriptions of the abbreviations like IHC, MTT etc have been supplemented in the revised manuscript.

比如审稿人提出:裂解液成分有问题

回复:We are very sorry for the mistake. Lentivirus-transduced cells were washed twice with PBS, and suspended in a lysis buffer (2% mercaptoethanol, 20% glycerol, and 4% SDS, in 100 mM Tris-HCl buffer, pH 6.8). The information for the lysis buffer has been corrected in the materials and methods.

技巧3:补充实验,耗时耗力,如果不补,只能argue

比如审稿人提出:补充正常皮肤细胞作对照

Tips:如果你真的不想补,或者正常细胞株,你也买不到,还是查一查正常细胞株的名字,告诉审稿人你确实是去努力过,只是事与愿违啊!

回复:Indeed, it will be more convincing if we get a comparative assessment on normal keratinocytes. However, the normal skin cell line TE 353.SK that we recently obtained could not be cultured stably under the condition of our lab at this time. We are also collecting human tissue samples from patients with primary melanoma and benign nevi. Based on our data, XXX expression will be analyzed in clinical samples by immunohistochemistry, and the correlation between XXX expression and the prognosis of melanoma will be determined in our subsequent investigations. Therefore, the referee’s concern is of importance for our further study, and we will show the results in our next paper for XXX.

比如审稿人提出:补充体内实验

Tips:补充动物实验,是审稿人最爱发的一招,其实一点不令人意外。既然躲不过,就要见招拆招,如果能补上,当然是给了漂亮的回马枪;要是没有条件补,或者实验来不及,也要尽量说的委婉点,假装你确实努力了,是审稿人给的时间太短了,我根本来不及啊!

回复:We are appreciative of the reviewer’s suggestion. Indeed, it will be more profound if we get the relevant results in vivo. We have purchased 10 thymus-null BALB/c nude mice (female, age 4-6 weeks) from the Animal Center of Chinese Academy of Medical Sciences. Osteosarcoma xenografts were established in nude mice according to a previous report (Gao et al., 2009) (我们去买了若干只小鼠,按照文献的方法操作). Briefly, control lentivirus or XXX gene shRNA-expressing lentivirus infected XXX cells (1×105) were suspended in 0.1 ml PBS and then injected subcutaneously into the proximal tibia of each anesthetized nude mice (n=5 in each group). Unfortunately, the xenografts could not grow after inoculation for three weeks (满怀欣喜的接种到动物身上,然而实验这东西,哪能一遍就成呢,我们做了一遍,结果没能成瘤,实在是悲剧了). The limitation of technical condition may be the main reason. Also, we doubt that the cell viability could be insufficient to initiate osteosarcoma tumorigenesis in vivo due to the long-distance transport. Therefore, we seek for the editor’s tolerance and understanding. Many thanks for your kind help!

然而,补充实验,还是逃不过的一劫,究竟是申请延期,再老老实实把实验做完,还是想投机取巧,argue一下,就看自己的运气了。一般情况,可以对照审稿人的意见综合权衡。高分文章,最好还是该补的全补了,低分文章,如果你觉得有80%的把握,完全可以凭你的劲爆人品成功拿下审稿人。

 
客服01
点击这里给我发消息